For comments, suggestions
Created with Raphaël 2.1.0 14.04.2017 Filing date 15.11.2018 Validation fee payment 31.03.2019 (A1) Patent application published 26.04.2025 19.08.2025 Can request protection in MD until

Request for EP validation pending


(210)Number of the EPO application17783236
(220)Filing date of the EPO application2017.04.14
(80)EPO patent specification publication (B)EPB nr. 08/2025, 2025.02.19
(110)EPO patent number3442602
(21)Number of the applicatione 2019 0237
(71)Name(s) of applicant(s), code of the countryResearch Institute at Nationwide Children's Hospital, US;
(72)Name(s) of inventor(s), code of the countryRODINO-KLAPAC Louise, US;
MENDELL Jerry R., US;
HELLER Kristin N., US;
(73)Name(s) of owner(s), code of the countryResearch Institute at Nationwide Children's Hospital, US;
(54)Title of the inventionADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY
(13)Kind-of-document code A1
(51)International Patent Classification A61K 48/00 (2006.01.01); C12N 15/11 (2006.01.01); C12N 15/113 (2010.01.01)
(19)CountryUS
(41)Date of publication of the application2019.03.31
(30)Priority201662323163 P, 2016.04.15, US; 201762473253 P, 2017.03.17, US
(86)International applicationPCT/US2017/027636, 2017.04.14
(87)International publicationWO 2017/181015, 2017.10.19
Up
/Inventions/details/3442602